The Pharma Data
MARCH 25, 2021
Real-world evidence is woven into the fabric of how we innovate and advance care for patients with breast cancer, supporting our randomized clinical trials,” said Chris Boshoff, M.D., However, this observational analysis differs from the randomized clinical trial in several ways.
The Pharma Data
FEBRUARY 8, 2021
Across clinical trials (PALOMA-1, PALOMA-2, PALOMA-3), 1.0% IBRANCE may impair fertility in males and has the potential to cause genotoxicity. Advise women not to breastfeed during IBRANCE treatment and for 3 weeks after the last dose because of the potential for serious adverse reactions in nursing infants.
The Pharma Data
MAY 13, 2021
Exposure to sorbitol during lactation causes metabolic alterations and genotoxic effects in rat offspring. based weight loss intervention in adults with obesity: A randomized clinical trial. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(16):5984-5988. DOI: 10.1073/pnas.1120794109.
Expert insights. Personalized for you.
52 
Let's personalize your content